Market Closed -
Swiss Exchange
11:30:44 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
70.55
CHF
|
+0.79%
|
|
-0.42%
|
-3.02%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,943
|
2,911
|
3,393
|
3,750
|
3,624
|
3,516
|
-
|
-
|
Enterprise Value (EV)
1 |
3,269
|
3,492
|
3,901
|
4,343
|
4,283
|
4,055
|
4,026
|
4,054
|
P/E ratio
|
23.7
x
|
17
x
|
20.3
x
|
22.8
x
|
22
x
|
20.4
x
|
19.2
x
|
17.9
x
|
Yield
|
3.01%
|
3.05%
|
3.06%
|
2.91%
|
3.02%
|
3.24%
|
3.35%
|
2.69%
|
Capitalization / Revenue
|
0.89
x
|
0.84
x
|
0.88
x
|
0.93
x
|
0.97
x
|
0.9
x
|
0.86
x
|
0.83
x
|
EV / Revenue
|
0.99
x
|
1
x
|
1.02
x
|
1.08
x
|
1.14
x
|
1.03
x
|
0.99
x
|
0.96
x
|
EV / EBITDA
|
12.6
x
|
11.3
x
|
14.9
x
|
17.4
x
|
17.7
x
|
13.7
x
|
12.9
x
|
12.2
x
|
EV / FCF
|
16.6
x
|
18.6
x
|
13.4
x
|
22.2
x
|
28.7
x
|
27
x
|
23.8
x
|
21.8
x
|
FCF Yield
|
6.02%
|
5.38%
|
7.46%
|
4.51%
|
3.49%
|
3.71%
|
4.21%
|
4.6%
|
Price to Book
|
2.97
x
|
2.78
x
|
2.77
x
|
3.02
x
|
2.46
x
|
2.35
x
|
2.24
x
|
2.17
x
|
Nbr of stocks (in thousands)
|
49,177
|
49,339
|
49,499
|
49,638
|
49,816
|
49,832
|
-
|
-
|
Reference price
2 |
59.85
|
59.00
|
68.55
|
75.55
|
72.75
|
70.55
|
70.55
|
70.55
|
Announcement Date
|
3/9/20
|
3/9/21
|
3/8/22
|
3/29/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,301
|
3,480
|
3,835
|
4,014
|
3,746
|
3,919
|
4,076
|
4,231
|
EBITDA
1 |
260.3
|
309.5
|
262.3
|
249.9
|
242.2
|
295.3
|
311.8
|
332.5
|
EBIT
1 |
166.9
|
168.6
|
213.1
|
200.8
|
191.3
|
215.4
|
227.4
|
246.5
|
Operating Margin
|
5.06%
|
4.85%
|
5.56%
|
5%
|
5.11%
|
5.5%
|
5.58%
|
5.83%
|
Earnings before Tax (EBT)
1 |
163.4
|
208.6
|
203
|
199.6
|
194.9
|
202.4
|
213.5
|
230.3
|
Net income
1 |
125
|
172.2
|
167.7
|
165.1
|
285.4
|
173.9
|
183.3
|
190.6
|
Net margin
|
3.79%
|
4.95%
|
4.37%
|
4.11%
|
7.62%
|
4.44%
|
4.5%
|
4.51%
|
EPS
2 |
2.530
|
3.480
|
3.380
|
3.320
|
3.310
|
3.462
|
3.675
|
3.946
|
Free Cash Flow
1 |
196.8
|
187.9
|
291.2
|
195.8
|
149.3
|
150.3
|
169.3
|
186.4
|
FCF margin
|
5.96%
|
5.4%
|
7.59%
|
4.88%
|
3.99%
|
3.83%
|
4.15%
|
4.41%
|
FCF Conversion (EBITDA)
|
75.62%
|
60.7%
|
110.99%
|
78.36%
|
61.66%
|
50.89%
|
54.3%
|
56.06%
|
FCF Conversion (Net income)
|
157.49%
|
109.07%
|
173.64%
|
118.58%
|
52.33%
|
86.44%
|
92.35%
|
97.78%
|
Dividend per Share
2 |
1.800
|
1.800
|
2.100
|
2.200
|
2.200
|
2.282
|
2.366
|
1.901
|
Announcement Date
|
3/9/20
|
3/9/21
|
3/8/22
|
3/29/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
---|
Net sales
1 |
1,690
|
1,789
|
-
|
1,978
|
1,960
|
2,054
|
1,851
|
EBITDA
1 |
105.3
|
180.2
|
-
|
-
|
152.6
|
126.2
|
143.9
|
EBIT
1 |
83.58
|
-
|
101.4
|
111.7
|
100
|
100.8
|
92.52
|
Operating Margin
|
4.94%
|
-
|
-
|
5.65%
|
5.1%
|
4.91%
|
5%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
66.17
|
106.1
|
-
|
88.38
|
82.91
|
82.22
|
187
|
Net margin
|
3.91%
|
5.93%
|
-
|
4.47%
|
4.23%
|
4%
|
10.1%
|
EPS
2 |
1.340
|
2.140
|
-
|
1.780
|
1.670
|
1.650
|
1.490
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/4/20
|
3/9/21
|
-
|
3/8/22
|
8/9/22
|
3/29/23
|
8/8/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
326
|
581
|
508
|
593
|
658
|
540
|
510
|
539
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.253
x
|
1.877
x
|
1.935
x
|
2.371
x
|
2.718
x
|
1.828
x
|
1.636
x
|
1.62
x
|
Free Cash Flow
1 |
197
|
188
|
291
|
196
|
149
|
150
|
169
|
186
|
ROE (net income / shareholders' equity)
|
14%
|
16.9%
|
14.7%
|
13.4%
|
21%
|
12.1%
|
12.3%
|
12.8%
|
ROA (Net income/ Total Assets)
|
6.6%
|
7.71%
|
6.95%
|
6.38%
|
10.2%
|
5.61%
|
5.84%
|
6.13%
|
Assets
1 |
1,895
|
2,234
|
2,412
|
2,589
|
2,802
|
3,101
|
3,139
|
3,112
|
Book Value Per Share
2 |
20.20
|
21.20
|
24.80
|
25.00
|
29.50
|
30.00
|
31.50
|
32.50
|
Cash Flow per Share
2 |
5.070
|
4.530
|
6.710
|
4.760
|
4.520
|
5.010
|
5.850
|
5.630
|
Capex
1 |
53.6
|
55.1
|
41.9
|
41.1
|
76.4
|
110
|
110
|
110
|
Capex / Sales
|
1.62%
|
1.58%
|
1.09%
|
1.02%
|
2.04%
|
2.8%
|
2.7%
|
2.6%
|
Announcement Date
|
3/9/20
|
3/9/21
|
3/8/22
|
3/29/23
|
3/12/24
|
-
|
-
|
-
|
Last Close Price
70.55
CHF Average target price
76.25
CHF Spread / Average Target +8.08% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.02% | 3.89B | | +14.23% | 69.5B | | -1.88% | 24.09B | | +7.11% | 8.2B | | -20.55% | 7.97B | | -4.06% | 7.84B | | +2.26% | 4.66B | | +17.12% | 4.32B | | +1.41% | 4.19B | | +21.42% | 3.62B |
Pharmaceuticals Wholesale
|